Schedule 13G ownership disclosure
INOVIO PHARMACEUTICALS INC
Common Stock · CUSIP: 45773H409
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Stonepine Capital Management, LLC
Shares: 1,434,997.00 · Class: 3.8%
- Stonepine Capital, L.P.
Shares: 1,434,997.00 · Class: 3.8%
- Stonepine GP, LLC
Shares: 1,434,997.00 · Class: 3.8%
- Jon M. Plexico
Shares: 1,434,997.00 · Class: 3.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-25-000331
- Form type
- SCHEDULE 13G/A
- Filer
- INOVIO PHARMACEUTICALS, INC.
- CIK
- CIK 1055726
- Filed
- May 14, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership